drugset / Trial / NCT00781456
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine Headaches
RandomizedParallel-groupDouble-blindPrevention
Summary
This study is being conducted to evaluate the efficacy of a 91-day extended cycle oral contraceptive compared to placebo for decreasing the frequency and severity of menstrually-related migraine headaches.
Timeline
- Start
- 2009-01
- Primary completion
- 2011-08
- Completion
- 2011-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 91-day Levonorgestrel Oral Contraceptive | Unknown | 30 ug | Oral |
| Subject | Levonorgestrel | Small molecule | 150 ug | Oral |